Understanding HIV-Mycobacteria synergism through comparative proteomics of intra-phagosomal mycobacteria during mono- and HIV co-infection

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ganji, Rakesh ^a   Dhali, Snigdha ^b   Rizvi, Arshad ^a   Rapole, Srikanth ^b   Banerjee, Sharmistha ^a  

^a UNIVERSITY OF HYDERABAD   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN;

AIDS RELATED COMPLEX; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MACROPHAGE; METABOLISM; MICROBIOLOGY; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; PHAGOSOME; PROTEOMICS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MACROPHAGES; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM TUBERCULOSIS; PHAGOSOMES; PROTEOMICS;

EID: 84959440301     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22060     Document Type: Article

References (60)

1. Pawlowski, A., Jansson, M., Skold, M., Rottenberg, M. E. & Kallenius, G. Tuberculosis and HIV co-infection. PLoS Pathog 8, e1002464, doi: 10.1371/journal.ppat.1002464 PPATHOGENS-D-11-01902 (2012).
2. Naidoo, K. et al. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial. An Intern Med 157, 313-324, doi: 1355683 10.7326/0003-4819-157-5-201209040-00004 (2012).
3. Sharma, S. K. & Soneja, M. HIV & immune reconstitution inflammatory syndrome (IRIS). Indian J Med Res 134, 866-877, doi: IndianJMedRes-2011-134-6-866-92632 10.4103/0971-5916.92632 (2011).
4. Naidoo, K., Padayatchi, N. & Abdool Karim, Q. HIV-Associated Tuberculosis. Clin Dev Immunol 2011, doi: 10.1155/2011/585919 (2011).
5. Primm, T. P., Lucero, C. A. & Falkinham, J. O. 3rd. Health impacts of environmental mycobacteria. Clin Microbiol Rev 17, 98-106 (2004).
6. McShane, P. J. & Glassroth, J. Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights. Chest, doi: 2422757 10.1378/chest.15-0458 (2015).
7. Goletti, D. et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 157, 1271-1278 (1996).
8. Pathak, S., Wentzel-Larsen, T. & Asjo, B. Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocytederived macrophages. Infect Immun 78, 4022-4032, doi: 10.1128/IAI.00106-10 (2010).
9. Kaufmann, S. H. & McMichael, A. J. Annulling A dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 11, S33-44, doi: 10.1038/nm1221 (2005).
10. Mattow, J. et al. Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics 6, 2485-2494 (2006).
11. Schnappinger, D. et al. Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J Exp Med 198, 693-704, doi: 10.1084/jem.20030846 (2003).
12. Monahan, I. M., Betts, J., Banerjee, D. K. & Butcher, P. D. Differential expression of mycobacterial proteins following phagocytosis by macrophages. Microbiology 147, 459-471 (2001).
13. Li, M. S. et al. cDNA-RNA subtractive hybridization reveals increased expression of mycocerosic acid synthase in intracellular Mycobacterium bovis BCG. Microbiology 147, 2293-2305 (2001).
14. Rienksma, R. A. et al. Comprehensive insights into transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencing. BMC Genomics 16, 34, doi: 10.1186/s12864-014-1197-2 (2015).
15. Carter, C. A. & Ehrlich, L. S. Cell biology of HIV-1 infection of macrophages. Annu Rev Microbiol 62, 425-443, doi: 10.1146/annurev.micro.62.081307.162758 (2008).
16. Guirado, E., Schlesinger, L. S. & Kaplan, G. Macrophages in tuberculosis: friend or foe. Semin Immunopathol 35, 563-583, doi: 10.1007/s00281-013-0388-2 (2013).
17. Tomlinson, G. S. et al. HIV-1 infection of macrophages dysregulates innate immune responses to Mycobacterium tuberculosis by inhibition of interleukin-10. J Infect Dis 209, 1055-1065, doi: 10.1093/infdis/jit621 (2014).
18. Mosser, D. M. The many faces of macrophage activation. J Leukoc Biol 73, 209-212 (2003).
19. Lawn, S. D., Butera, S. T. & Shinnick, T. M. Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. Microbes Infect 4, 635-646, doi: S1286457902015824 (2002).
20. Diedrich, C. R. & Flynn, J. L. HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun 79, 1407-1417, doi: 10.1128/IAI.01126-10 (2011).
21. Ganji, R. et al. Proteomics approach to understand reduced clearance of mycobacteria and high viral titers during HIV-mycobacteria co-infection. Cell Microbiol, doi: 10.1111/cmi.12516 (2015).
22. Lew, J. M., Kapopoulou, A., Jones, L. M. & Cole, S. T. TubercuList - 10 years after. Tuberculosis (Edinb) 91, 1-7, doi: 10.1016/j. tube.2010.09.008 (2011).
23. Ramage, H. R., Connolly, L. E. & Cox, J. S. Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet 5, e1000767, doi: 10.1371/journal.pgen.1000767 (2009).
24. Rodriguez, G. M., Voskuil, M. I., Gold, B., Schoolnik, G. K. & Smith, I. ideR, An essential gene in mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response. Infect Immun 70, 3371-3381 (2002).
25. Dussurget, O., Rodriguez, M. & Smith, I. An ideR mutant of Mycobacterium smegmatis has derepressed siderophore production and An altered oxidative-stress response. Mol Microbiol 22, 535-544 (1996).
26. Kordulakova, J. et al. Identification of the required acyltransferase step in the biosynthesis of the phosphatidylinositol mannosides of mycobacterium species. J Biol Chem 278, 36285-36295, doi: 10.1074/jbc.M303639200 (2003).
27. Daniel, J. et al. Induction of A novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into A dormancy-like state in culture. J Bacteriol 186, 5017-5030, doi: 10.1128/JB.186.15.5017-5030.2004 186/15/5017 (2004).
28. Jain, M. & Cox, J. S. Interaction between polyketide synthase and transporter suggests coupled synthesis and export of virulence lipid in M. tuberculosis. PLoS Pathog 1, e2, doi: 10.1371/journal.ppat.0010002 (2005).
29. Ranjbar, S. et al. HIV-1 replication is differentially regulated by distinct clinical strains of Mycobacterium tuberculosis. PLoS One 4, e6116, doi: 10.1371/journal.pone.0006116 (2009).
30. Russell, D. G. Phagosomes, fatty acids and tuberculosis. Nat Cell Biol 5, 776-778, doi: 10.1038/ncb0903-776 (2003).
31. Sirakova, T. D. et al. Identification of A diacylglycerol acyltransferase gene involved in accumulation of triacylglycerol in Mycobacterium tuberculosis under stress. Microbiology 152, 2717-2725, doi: 152/9/2717 10.1099/mic.0.28993-0 (2006).
32. Goren, M. B., Brokl, O. & Schaefer, W. B. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: phthiocerol dimycocerosate and the attenuation indicator lipid. Infect Immun 9, 150-158 (1974).
33. Makinoshima, H. & Glickman, M. S. Regulation of Mycobacterium tuberculosis cell envelope composition and virulence by intramembrane proteolysis. Nature 436, 406-409, doi: 10.1038/nature03713 (2005).
34. Sklar, J. G., Makinoshima, H., Schneider, J. S. & Glickman, M. S. M.. tuberculosis intramembrane protease Rip1 controls transcription through three anti-sigma factor substrates. Mol Microbiol 77, 605-617, doi: MMI7232 10.1111/j.1365-2958.2010.07232.x (2010).
35. Vats, A. et al. Retrobiosynthetic approach delineates the biosynthetic pathway and the structure of the acyl chain of mycobacterial glycopeptidolipids. J Biol Chem 287, 30677-30687, doi: 10.1074/jbc.M112.384966 (2012).
36. Schneider, J. S., Sklar, J. G. & Glickman, M. S. The Rip1 protease of Mycobacterium tuberculosis controls the SigD regulon. J Bacteriol 196, 2638-2645, doi: 10.1128/JB.01537-14 (2014).
37. Feltcher, M. E., Gibbons, H. S., Ligon, L. S. & Braunstein, M. Protein export by the mycobacterial SecA2 system is determined by the preprotein mature domain. J Bacteriol 195, 672-681, doi: 10.1128/JB.02032-12 (2013).
38. Sassetti, C. M., Boyd, D. H. & Rubin, E. J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48, 77-84, doi: 10.1046/j.1365-2958.2003.03425 (2003).
39. Serafini, A., Pisu, D., Palu, G., Rodriguez, G. M. & Manganelli, R. The ESX-3 secretion system is necessary for iron and zinc homeostasis in Mycobacterium tuberculosis. PLoS One 8, e78351, doi: 10.1371/journal.pone.0078351 PONE-D-13-29715 (2013).
40. Agranoff, D., Monahan, I. M., Mangan, J. A., Butcher, P. D. & Krishna, S. Mycobacterium tuberculosis expresses A novel pHdependent divalent cation transporter belonging to the Nramp family. J Exp Med 190, 717-724 (1999).
41. Papp-Wallace, K. M. & Maguire, M. E. Manganese transport and the role of manganese in virulence. Annu Rev Microbiol 60, 187-209, doi: 10.1146/annurev.micro.60.080805.142149 (2006).
42. Novoa-Aponte, L. et al. In silico identification and characterization of the ion transport specificity for P-type ATPases in the Mycobacterium tuberculosis complex. BMC Struct Biol 12, 25, doi: 10.1186/1472-6807-12-25 (2012).
43. Abdallah, A. M. et al. The ESX-5 secretion system of Mycobacterium marinum modulates the macrophage response. J Immunol 181, 7166-7175, doi: 181/10/7166 (2008).
44. Bottai, D. et al. Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. Mol Microbiol 83, 1195-1209, doi: 10.1111/j.1365-2958.2012.08001.x (2012).
45. Siegrist, M. S. et al. Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition. Proc Natl Acad Sci USA 106, 18792-18797, doi: 10.1073/pnas.0900589106 (2009).
46. McKinney, J. D. et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406, 735-738, doi: 10.1038/35021074 (2000).
47. Sturgill-Koszycki, S., Haddix, P. L. & Russell, D. G. The interaction between Mycobacterium and the macrophage analyzed by twodimensional polyacrylamide gel electrophoresis. Electrophoresis 18, 2558-2565, doi: 10.1002/elps.1150181411 (1997).
48. Hou, J. Y., Graham, J. E. & Clark-Curtiss, J. E. Mycobacterium avium genes expressed during growth in human macrophages detected by selective capture of transcribed sequences (SCOTS). Infect Immun 70, 3714-3726 (2002).
49. Bange, F. C., Brown, A. M. & Jacobs, W. R. Jr. Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages. Infect Immun 64, 1794-1799 (1996).
50. McAdam, R. A. et al. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect Immun 63, 1004-1012 (1995).
51. Ramakrishnan, T., Murthy, P. S. & Gopinathan, K. P. Intermediary metabolism of mycobacteria. Bacteriol Rev 36, 65-108 (1972).
52. Foster, J. W. & Moat, A. G. Nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism in microbial systems. Microbiol Rev 44, 83-105 (1980).
53. Jang, J. et al. Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ. Microbiology 156, 1619-1631, doi: 10.1099/mic.0.038133-0 (2010).
54. Lee, B. Y. et al. The Mycobacterium bovis bacille Calmette-Guerin phagosome proteome. Mol Cell Proteomics 9, 32-53, doi: 10.1074/mcp.M900396-MCP200 (2010).
55. Singhal, N., Sharma, P., Kumar, M., Joshi, B. & Bisht, D. Analysis of intracellular expressed proteins of Mycobacterium tuberculosis clinical isolates. Proteome Sci 10, 14, doi: 10.1186/1477-5956-10-14 (2012).
56. Kruh, N. A., Troudt, J., Izzo, A., Prenni, J. & Dobos, K. M. Portrait of A pathogen: the Mycobacterium tuberculosis proteome in vivo. PLoS One 5, e13938, doi: 10.1371/journal.pone.0013938 (2010).
57. Yajko, D. M. et al. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J Clin Microbiol 33, 2324-2327 (1995).
58. Kumar, M. et al. MicroRNA let-7 modulates the immune response to Mycobacterium tuberculosis infection via control of A20, An inhibitor of the NF-kappaB pathway. Cell Host Microbe 17, 345-356, doi: 10.1016/j.chom.2015.01.007 (2015).
59. Stover, C. K. et al. New use of BCG for recombinant vaccines. Nature 351, 456-460, doi: 10.1038/351456a0 (1991).
60. Chatrath, S., Gupta, V. K., Dixit, A. & Garg, L. C. The Rv1651c-encoded PE-PGRS30 protein expressed in Mycobacterium smegmatis exhibits polar localization and modulates its growth profile. FEMS Microbiol Lett 322, 194-199, doi: 10.1111/j.1574-6968.2011.02354.x (2011).